The effect of scatter photocoagulation on the perfusion of iatrogenic choriovitreal neovascularisation (CVN) has been assessed by a randomised trial in 35 CVN lesions in 18 eyes with proliferative sickle retinopathy. No difference in size or vascularity ofCVN lesions was apparent between the nine treated and nine control eyes over a median follow-up of42 months. Scatter photocoagulation by the stated protocol was not effective in the treatment of CVN. associated with rapid enlargement of the lesion,' vitreous haemorrhage, and traction detachment of the retina.2 In proliferative retinal vascular disease clinical evidence of a link between retinal ischaemia and retinal neovascularisation is well known. Hypotheses for the mechanism include the roles of retinal hypoxia, proteolytic enzymes on basement membrane collagen, insulin-like growth factors, and retina-derived growth factors.5 On the assumption that these influences induce and maintain the ingrowth of choroidal vessels the effect oflocal retinal ablation has been investigated.
The vaso-occlusive process of sickle cell disease results in peripheral retinal ischaemia which may be associated with the development of proliferative sickle retinopathy (PSR). Treatment of PSR has been attempted by photocoagulation of the feeding arterioles in order to render these lesions avascular and therefore less prone to sight threatening complications. However, attempted closure of these feeding vessels requires high energy photocoagulation burns, which often disrupt Bruch's membrane. Ingrowth of choroidal vessels may result and is especially common following xenon arc photocoagulation. I 6 /36, and 6/60) for two consecutive visits at least three months apart was regarded as significant. Angiograms were examined by stereoscopic technique. An independent examiner (ELC) examined the angiograms but not the eyes to reduce observer bias. The response was defined as progression (increase in number or size of the previous capillary bed), regression (a decrease of the above), and cure (non-perfusion).
Results
In two control eyes vitreous haemorrhage reduced visual acuity, but this improved to normal with resolution ofthe haemorrhage within three months. The visual acuity in all other treated and control eyes remained unchanged.
Perfusion continued in all treated and control eyes. Of 11 CVN lesions in each group with angiograms adequate for assessment of capillary structure the vessel systems increased in size in two treated cases and four controls, and remained stable or decreased in size in nine treated cases and seven controls, the difference failing to reach statistical significance (Fisher's exact test, p=031).
Discussion
The rationale of the trial was based on the concept that the maintenance of choriovitreal neovascularisation may depend on humoral factors released by adjacent ischaemic retina. This assumption derived from the analogy to the effect of scatter photocoagulation in causing regression of retinal neovascularisation in retinal vein obstruction,8 and proliferative retinopathy associated with diabetes9 and sickle cell disease.IO-The success of scatter photocoagulation in causing a prompt and sustained regression of choriovitreal neovascularisation developing after photocoagulation for choroidal melanomata'3 is also consistent with this concept, though effects are likely to be due to photocoagulation of the tumour as well as the retina.
The present study suggests that scatter photocoagulation, as conducted by the stated protocol, has no effect in reducing the vascularity of iatrogenic choroidal neovascularisation in pro- 
